Portable-electronic device
Latest Novartis AG Patents:
- Antibody molecules to LAG-3 and uses thereof
- Crystalline forms OF N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide
- Crystalline forms of N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide
- Pyrazolopyridine derivatives and uses thereof
- Methods for improving the efficacy and expansion of immune cells
Description
The broken lines represent boundaries or environmental features, and form no part of the claimed design.
Claims
The ornamental design for a portable-electronic device, as shown and described.
Referenced Cited
Patent History
Patent number: D616993
Type: Grant
Filed: Mar 13, 2009
Date of Patent: Jun 1, 2010
Assignee: Novartis AG (Basel)
Inventors: Jan Muis (Utrecht), Lukas Fransen (Middelburg), Rutger Alexander Brest van Kempen (Noord Scharwoude), Alexander Adriaan Huntelerslag (Zuld-Scharwoude)
Primary Examiner: Lisa P Lichtenstein
Attorney: Montgomery, McCracken, Walker & Rhoads, LLP
Application Number: 29/333,688
Type: Grant
Filed: Mar 13, 2009
Date of Patent: Jun 1, 2010
Assignee: Novartis AG (Basel)
Inventors: Jan Muis (Utrecht), Lukas Fransen (Middelburg), Rutger Alexander Brest van Kempen (Noord Scharwoude), Alexander Adriaan Huntelerslag (Zuld-Scharwoude)
Primary Examiner: Lisa P Lichtenstein
Attorney: Montgomery, McCracken, Walker & Rhoads, LLP
Application Number: 29/333,688
Classifications
Current U.S. Class:
Patient Monitor Or Diagnostic Instrument Not Elsewhere Specified (50) (D24/186)